Chen, Dongxuan
Adam, Dillon C.
Lau, Yiu-Chung https://orcid.org/0000-0001-6618-9094
Wang, Dong
Lim, Wey Wen https://orcid.org/0000-0001-8514-2048
Ho, Faith
Tsang, Tim K. https://orcid.org/0000-0001-5037-6776
Lau, Eric H. Y.
Wu, Peng https://orcid.org/0000-0003-1157-9401
Wallinga, Jacco
Cowling, Benjamin J. https://orcid.org/0000-0002-6297-7154
Ali, Sheikh Taslim https://orcid.org/0000-0002-8631-9076
Funding for this research was provided by:
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (22210672)
Research Grants Council, University Grants Committee (C7123-20G; T11-705/21-N)
Article History
Received: 19 June 2024
Accepted: 28 May 2025
First Online: 1 July 2025
Competing interests
: B.J.C. consults for AstraZeneca, Fosun Pharma, GSK, Haleon, Moderna, Novavax, Pfizer, Roche and Sanofi Pasteur. The authors report no other potential conflicts of interest.